Pathogen: clinical or host-associated sample from ... - BioSample - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

Result Filters

Pathogen: clinical or host-associated sample from Staphylococcus aureus

Identifiers: BioSample: SAMN41091881; Sample name: BWH_1895_S_aur; SRA: SRS21133315

Organism: Staphylococcus aureus
cellular organisms; Bacteria; Bacillati; Bacillota; Bacilli; Bacillales; Staphylococcaceae; Staphylococcus

Package: Pathogen: clinical or host-associated; version 1.0

Attributes

isolate	BWH_1895_S_aur
collected by	Brigham and Women's Hospital
collection date	2024
geographic location	USA:Boston
host	Homo sapiens
host disease	Screening culture
isolation source	Nasal perirectal swab
latitude and longitude	42.3362 N 71.1067 W
host age	<18

BioProject: PRJNA278886
Retrieve all samples from this project

Submission: Brigham and Women's Hospital, Jay Worley; 2024-04-26

Antibiogram
Antibiotic	Resistance phenotype	Measurement sign	Measurement	Measurement units	Laboratory typing method	Laboratory typing platform	Vendor	Laboratory typing method version or reagent	Testing standard
trimethoprim-sulfamethoxazole	susceptible	<=	9.5/0.5	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
linezolid	susceptible	==	2	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
tetracycline	susceptible	<=	1	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
vancomycin	susceptible	==	1	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
daptomycin	susceptible	==	0.5	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
gentamicin	susceptible	<=	0.5	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
ciprofloxacin	susceptible	<=	0.5	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
rifampin	susceptible	<=	0.5	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
minocycline	susceptible	<=	0.5	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
clindamycin	susceptible	==	0.25	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
oxacillin	susceptible	<=	0.25	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
erythromycin	susceptible	<=	0.25	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
moxifloxacin	susceptible	<=	0.25	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
levofloxacin	susceptible	==	0.25	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
ceftaroline	susceptible	==	0.25	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
tigecycline	susceptible	<=	0.12	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI

Accession:: SAMN41091881
ID:: 41091881

BioProject SRA Nucleotide

Supplemental Content

Related information

BioProject
BioProject links
SRA
Links to SRA experiments
Nucleotide
Nucleotide links
Assembly
Assembly
Taxonomy
Links to Taxonomy

Recent activity

Clear Turn Off Turn On

Pathogen: clinical or host-associated sample from Staphylococcus aureus
Pathogen: clinical or host-associated sample from Staphylococcus aureus

biosample
Pathogen: clinical or host-associated sample from Clostridioides difficile
Pathogen: clinical or host-associated sample from Clostridioides difficile

biosample
Exportin-1 C-terminal domain-containing protein [Caenorhabditis elegans]
Exportin-1 C-terminal domain-containing protein [Caenorhabditis elegans]
gi|1831517177|ref|NP_001367571.1|

Protein
PREDICTED: Mus musculus eva-1 homolog B (Eva1b), transcript variant X1, mRNA
PREDICTED: Mus musculus eva-1 homolog B (Eva1b), transcript variant X1, mRNA
gi|1907155693|ref|XM_006503036.5|

Nucleotide
Schizosaccharomyces pombe non-coding RNA (SPOM_SPNCRNA.6217), lncRNA
Schizosaccharomyces pombe non-coding RNA (SPOM_SPNCRNA.6217), lncRNA
gi|2745687992|ref|NR_195567.1|

Nucleotide

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

You are here: NCBI > DNA & RNA > BioSample